Russia which has the fourth-most coronavirus cases in the world is apparently running ahead of other countries in the global COVID-19 vaccine race. A few days ago Russia's Sechenov University announced that it had successfully completed clinical trials of a coronavirus vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology. Now the country is set to start human trials of its second COVID-19 vaccine. According to a media report the Russian State Research Center of Virology and Biotechnology Vector has been granted permission to conduct clinical trials of its vaccine against coronavirus. Russian healthcare watchdog Rospotrebnadzor has